Brief: Xvivo Perfusion Q4 Operating income at SEK 6.1 mln
Feb 8 (Reuters) - Xvivo Perfusion AB XVIVO.ST :
* (PUBL) REPORT ON OPERATIONS 2018
* Q4 TOTAL NET SALES IN QUARTER AMOUNTED TO SEK 58.4 (41.6) MILLION,
* Q4 OPERATING INCOME AMOUNTED TO SEK 6.1 (4.7) MILLION
Source text for Eikon: ID:nWkrG2VNV
Further company coverage: XVIVO.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength